NA Selank 50 mg

NA-Selank research peptide is a modified synthetic neuropeptide derived from Selank, a compound originally developed in Russia as an analogue of the endogenous neuropeptide tuftsin. NA-Selank incorporates an N-terminal acetyl modification designed to improve peptide stability and resistance to enzymatic degradation, enhancing its bioavailability in experimental models while preserving its core neurobiological characteristics.

This NA-Selank research peptide is primarily studied within neuroscience and neuroendocrine research for its anxiolytic, stress-modulating, and cognitive-supporting properties. Preclinical investigations have explored its influence on GABAergic neurotransmission and its potential to modulate the expression of brain-derived neurotrophic factor (BDNF), a key regulator of neuronal growth and plasticity (Semenova et al., 2008 — Bulletin of Experimental Biology and Medicine).

(Eremin et al., 2008 — Bulletin of Experimental Biology and Medicine).

Further research has examined NA-Selank's effects on cytokine regulation and immune-neuroendocrine interactions, positioning it as a multifunctional compound in translational neuroscience research. Its structural stability compared to unmodified Selank makes it a preferred candidate for controlled experimental settings (Zozulya et al., 2012 — Drugs of the Future).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.